Genetic Contribution of Variants near SORT1 and APOE on LDL Cholesterol Independent of Obesity in Children

PLoS One. 2015 Sep 16;10(9):e0138064. doi: 10.1371/journal.pone.0138064. eCollection 2015.

Abstract

Objective: To assess potential effects of variants in six lipid modulating genes (SORT1, HMGCR, MLXIPL, FADS2, APOE and MAFB) on early development of dyslipidemia independent of the degree of obesity in children, we investigated their association with total (TC), low density lipoprotein (LDL-C), high density lipoprotein (HDL-C) cholesterol and triglyceride (TG) levels in 594 children. Furthermore, we evaluated the expression profile of the candidate genes during human adipocyte differentiation.

Results: Expression of selected genes increased 10(1) to >10(4) fold during human adipocyte differentiation, suggesting a potential link with adipogenesis. In genetic association studies adjusted for age, BMI SDS and sex, we identified significant associations for rs599839 near SORT1 with TC and LDL-C and for rs4420638 near APOE with TC and LDL-C. We performed Bayesian modelling of the combined lipid phenotype of HDL-C, LDL-C and TG to identify potentially causal polygenic effects on this multi-dimensional phenotype and considering obesity, age and sex as a-priori modulating factors. This analysis confirmed that rs599839 and rs4420638 affect LDL-C.

Conclusion: We show that lipid modulating genes are dynamically regulated during adipogenesis and that variants near SORT1 and APOE influence lipid levels independent of obesity in children. Bayesian modelling suggests causal effects of these variants.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Vesicular Transport / genetics*
  • Apolipoproteins E / genetics*
  • Bayes Theorem
  • Child
  • Cholesterol, LDL / blood*
  • Dyslipidemias / blood*
  • Dyslipidemias / etiology*
  • Dyslipidemias / pathology
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Male
  • Obesity / blood
  • Obesity / complications*
  • Obesity / pathology
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide / genetics*

Substances

  • Adaptor Proteins, Vesicular Transport
  • Apolipoproteins E
  • Cholesterol, LDL
  • sortilin

Grants and funding

This work was supported by grants from the German Research Council (DFG) for the Clinical Research Center “Obesity Mechanisms” CRC1052/1 C05 and the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001 (IFB AdiposityDiseases), and the European Community’s Seventh Framework Programme (FP7/2007–2013) project Beta-JUDO under grant agreement n° 279153 to A.K. The work of A.G. was supported in part by the German Federal Research Ministry (BMBF), grant PROGRESS (01KI1010I). M.S. was funded by LIFE – Leipzig Research Center for Civilization Diseases, University of Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.